|

Trastuzumab+Pertuzumab Clinical Trials

5 actively recruiting trials across 1 location

Also known as: Herceptin, Herceptin + Perjeta, Phesgo

Pipeline

Phase 2: 2Phase 3: 2

Top Sponsors

  • Seoul National University Bundang Hospital1
  • Massachusetts General Hospital1
  • Henan Cancer Hospital1
  • Helsinki University Central Hospital1
  • German Cancer Research Center1

Indications

  • Cancer5
  • Solid Tumor2
  • Breast Cancer2
  • Stage III Colon Cancer1
  • Metastatic Colon Cancer1

Other4 trials

Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer
Phase 3
Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)
Phase 2
KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II
The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs
Phase 2

Boston, Massachusetts1 trial

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

Massachusetts General Hospital

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.